
-
2004
Company Description
Celtaxsys is a biopharmaceutical company, engages in developing and testing drug compounds for treating cancer.
Celtaxsys, is a biopharmaceutical company, engages in developing and testing drug compounds for treating cancer, and inflammatory and autoimmune diseases. Its technology manipulates immune cell migration as a treatment for cancer, inflammation, and organ/tissue rejection. The company's drug compounds are designed to block the protective mechanisms created by certain tumors to prevent attack by immune system cells.
-
Manufacturer:
Science and Engineering -
Formed:
2004 -
Company Website:
-
Company E-mail:
-
Company Address:
ATDC Biosciences Center, 0390, 311 Ferst DriveAtlanta, GAUnited States -
CEO:
- Greg Duncan
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits